Mondor's disease, a superficial thrombophlebitis, is a common complication of thoracoabdominal wall surgeries. While most patients experience disease resolution with expectant management, occasionally the disease may persist. The authors present a case of a 49-year-old woman who had persistent, symptomatic Mondor's disease 15 months status post-breast augmentation. The patient responded rapidly to intralesional triamcinolone injections resulting in complete disease resolution. To the authors' knowledge, this is the first report of intralesional corticosteroids being used to treat this common surgical complication.